Short Communication
暂无分享,去创建一个
L. Notarangelo | R. Badolato | A. Mantovani | B. Assael | P. Melotti | A. Plebani | C. Mazza | S. Rahimi | H. Mokhtari | S. Shahi | G. Savoldi | M. Chiarini | C. Sabelli | C. Garlanda | R. Padoan | N. Ghasemi
[1] M. Eghbal,et al. A Scientometric Study of PubMed-Indexed Endodontic Articles: A Comparison between Iran and Other Regional Countries , 2012, Iranian endodontic journal.
[2] M. Eghbal,et al. Published Endodontic Articles in PubMed-Indexed Journals from Iran , 2012, Iranian endodontic journal.
[3] V. Schirrmacher,et al. Clonal analysis of expression of tumor-associated transplantation antigens and of metastatic capacity , 2004, Cancer Immunology, Immunotherapy.
[4] D. Schwartz,et al. Tumor invasion and host extracellular matrix , 2004, Cancer and Metastasis Reviews.
[5] V. Schirrmacher,et al. Mechanism of Transendothelial Cell Passage and Matrix Degradation by Metastatic Tumor Cells , 1987 .
[6] H. Furthmayr,et al. Isolation and characterization of basement membrane and cell proteoheparan sulphates from HR9 cells. , 1986, European journal of biochemistry.
[7] M. Poupon,et al. Solubilization and degradation of extracellular matrix by various metastatic cell lines derived from a rat rhabdomyosarcoma. , 1986, Journal of the National Cancer Institute.
[8] V. Schirrmacher,et al. Involvement of both heparanase and plasminogen activator in lymphoma cell‐mediated degradation of heparan sulfate in the subendothelial extracellular matrix , 1986, Journal of cellular physiology.
[9] M. Lyon,et al. Structure and function of heparan sulphate proteoglycans. , 1986, The Biochemical journal.
[10] P. Mühlradt,et al. Glycoconjugates of murine tumor lines with different metastatic capacities. II. Diversity of glycolipid composition , 1985, International journal of cancer.
[11] Z. Fuks,et al. Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells , 1985, International journal of cancer.
[12] Z. Fuks,et al. Characterization of an extracellular matrix-degrading protease derived from a highly metastatic tumor cell line. , 1985, European journal of cancer & clinical oncology.
[13] V. Schirrmacher,et al. Glycoconjugates of murine tumor lines with different metastatic capacities. I. Differences in fucose utilization and in glycoprotein patterns , 1984, International journal of cancer.
[14] R. Kramer,et al. Selective degradation of basement membrane macromolecules by metastatic melanoma cells. , 1984, Journal of the National Cancer Institute.
[15] Z. Fuks,et al. Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis. , 1983, Cancer research.
[16] T. Irimura,et al. Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines. , 1983, Science.
[17] P. Altevogt,et al. Metastatic potential severely altered by changes in tumor cell adhesiveness and cell-surface sialylation , 1983, The Journal of experimental medicine.
[18] Z. Fuks,et al. Lymphoma cell interaction with cultured vascular endothelial cells and with the subendothelial basal lamina: attachment, invasion and morphological appearance. , 1983, Invasion & metastasis.
[19] P. Altevogt,et al. Different expression of Lyt differentiation antigens and cell surface glycoproteins by a murine T lymphoma line and its highly metastatic variant , 1982, European journal of immunology.
[20] M. Lohmann‐Matthes,et al. Tumor metastases and cell‐mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo , 1979, International journal of cancer.
[21] M. Höök,et al. Glycosaminoglycans and their binding to biological macromolecules. , 1978, Annual review of biochemistry.